The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
The role of subchondral bone remodeling in osteoarthritis: Reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model
Abstract
Objective: It has been suggested that subchondral bone remodeling plays a role in the progression of osteoarthritis (OA). To test this hypothesis, we characterized the changes in the rat anterior cruciate ligament transection (ACLT) model of OA and evaluated the effects of alendronate (ALN), a potent inhibitor of bone resorption, on cartilage degradation and on osteophyte formation. Methods: Male Sprague‐Dawley rats underwent ACLT or sham operation of the right knee. Animals were then treated with ALN (0.03 and 0.24 μg/kg/week subcutaneously) and necropsied at 2 or 10 weeks postsurgery. OA changes were evaluated. Subchondral bone volume and osteophyte area were measured by histomorphometric analysis. Coimmunostaining for transforming growth factor β (TGFβ), matrix metalloproteinase 9 (MMP‐9), and MMP‐13 was performed to investigate the effect of ALN on local activation of TGFβ. Results: ALN was chondroprotective at both dosages, as determined by histologic criteria and collagen degradation markers. ALN suppressed subchondral bone resorption, which was markedly increased 2 weeks postsurgery, and prevented the subsequent increase in bone formation 10 weeks postsurgery, in the untreated tibial plateau of ACLT joints. Furthermore, ALN reduced the incidence and area of osteophytes in a dose‐dependent manner. ALN also inhibited vascular invasion into the calcified cartilage in rats with OA and blocked osteoclast recruitment to subchondral bone and osteophytes. ALN treatment reduced the local release of active TGFβ, possibly via inhibition of MMP‐13 expression in articular cartilage and MMP‐9 expression in subchondral bone. Conclusion: Subchondral bone remodeling plays an important role in the pathogenesis of OA. ALN or other inhibitors of bone resorption could potentially be used as disease‐modifying agents in the treatment of OA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,995
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Control of osteoblast function and regulation of bone mass
Harada, S.-I., & Rodan, G. A. (2003) · Nature · doi:10.1038/nature01660 · Cited by 1,444
Self-citationAlendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Role of Subchondral Bone in the Initiation and Progression of Cartilage Damage
RADIN, E. L., & ROSE, R. M. (1986) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198612000-00005 · Cited by 1,075
Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention Trial
Black, D. M., Thompson, D. E., Bauer, D. C., Ensrud, K., Musliner, T., Hochberg, M. C., Nevitt, M. C., Suryawanshi, S., & Cummings, S. R. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6953 · Cited by 982
Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.
Wood, J., Bonjean, K., Ruetz, S., Bellahcène, A., Devy, L., Foidart, J. M., Castronovo, V., & Green, J. R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035295 · Cited by 854
Regulation of Fracture Repair by Growth Factors
Bolander, M. E. (1992) · Experimental Biology and Medicine · doi:10.3181/00379727-200-43410a · Cited by 636
Chavassieux, P. M., Arlot, M. E., Reda, C., Wei, L., Yates, A. J., & Meunier, P. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119668 · Cited by 523
Dieppe, P., Cushnaghan, J., Young, P., & Kirwan, J. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.8.557 · Cited by 430
Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts
Dallas, S. L., Rosser, J. L., Mundy, G. R., & Bonewald, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111663200 · Cited by 414
The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats
Seedor, J. G., Quartuccio, H. A., & Thompson, D. D. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060405 · Cited by 407
SAXNE, T., & HEINEGÅRD, D. (1992) · Rheumatology · doi:10.1093/rheumatology/31.9.583 · Cited by 344
Bakker, A. C., van de Loo, F. A. J., van Beuningen, H. M., Sime, P., van Lent, P. L. E. M., van der Kraan, P. M., Richards, C. D., & van den Berg, W. B. (2001) · Osteoarthritis and Cartilage · doi:10.1053/joca.2000.0368 · Cited by 291
Dedrick, D. K., Goldstein, S. A., Brandt, K. D., O'Connor, B. L., Goulet, R. W., & Albrecht, M. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361019 · Cited by 268
Burr, D. B., & Schaffler, M. B. (1997) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19970515)37:4<343::aid-jemt9>3.0.co;2-l · Cited by 236
Osteoblastic Responses to TGF-β during Bone Remodeling
Erlebacher, A., Filvaroff, E. H., Ye, J.-Q., & Derynck, R. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.7.1903 · Cited by 234
Schlaak, J., Pfers, I., Büschenfelde, K. H. M. Z., & Märker‐Hermann, E. (1996) · PubMed · Cited by 217
Seibel, M. J., Duncan, A., & Robins, S. P. (1989) · PubMed · Cited by 213
MMP Inhibition and Downregulation by Bisphosphonates
TERONEN, O., HEIKKILÄ, P., KONTTINEN, Y. T., LAITINEN, M., SALO, T., HANEMAAIJER, R., TERONEN, A., MAISI, P., & SORSA, T. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07702.x · Cited by 200
The importance of subchondral bone in osteoarthrosis
Burr, D. B. (1998) · Current Opinion in Rheumatology · doi:10.1097/00002281-199805000-00017 · Cited by 196
Vilı́m, V, Olejárová, M., Macháček, S., Gatterová, J., Kraus, V. B., & Pavelka, K. (2002) · Osteoarthritis and Cartilage · doi:10.1053/joca.2002.0819 · Cited by 182
Expression and Regulation of Aggrecanase in Arthritis: The Role of TGF-β
Yamanishi, Y., Boyle, D. L., Clark, M., Maki, R. A., Tortorella, M. D., Arner, E. C., & Firestein, G. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1405 · Cited by 171
ORWOLL, E. S. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70009-8 · Cited by 155
Synovial fluid cytokine concentrations as possible prognostic indicators in the ACL‐deficient knee
Cameron, M. L., Fu, F. H., Paessler, H. H., Schneider, M., & Evans, C. H. (1994) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/bf01552652 · Cited by 150
The STR/ort mouse and its use as a model of osteoarthritis
Mason, R. M., Chambers, M. G., Flannelly, J., Gaffen, J. D., Dudhia, J., & Bayliss, M. T. (2001) · Osteoarthritis and Cartilage · doi:10.1053/joca.2000.0363 · Cited by 131
The Integrin Ligand Echistatin Prevents Bone Loss in Ovariectomized Mice and Rats
Yamamoto, M., Fisher, J., Gentile, M., Seedor, J. G., Leu, C., Rodan, S. B., & Rodan, G. A. (1998) · Endocrinology · doi:10.1210/endo.139.3.5831 · Cited by 127
Self-citationTransforming Growth Factor Beta: An Autocrine Regulator of Chondrocytes
Rosier, R. N., O’Keefe, R. J., Crabb, I. D., & Puzas, J. E. (1989) · Connective Tissue Research · doi:10.3109/03008208909023900 · Cited by 125
Manicourt, D.-H., Altman, R. D., Williams, J. M., Devogelaer, J., Egeren, A. V., Lenz, M. E., Pietryla, D., & Thonar, E. J. ‐. A. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6<1159::aid-anr12>3.0.co;2-q · Cited by 122
Biochemical evidence for altered subchondral bone collagen metabolism in osteoarthritis of the hip
Mansell, J. P., Tarlton, J. F., & Bailey, A. J. (1997) · Rheumatology · doi:10.1093/rheumatology/36.1.16 · Cited by 116
Hayami, T., Funaki, H., Yaoeda, K., Mitui, K., Yamagiwa, H., Tokunaga, K., Hatano, K., Kondo, J., Hiraki, Y., Yamamoto, T., et al. (2003) · PubMed · Cited by 109
Self-citationHeikkilä, P., Teronen, O. P., Moilanen, M., Konttinen, Y. T., Hanemaaijer, R., Laitinen, M., Maisi, P. S., van der Pluijm, G., Bartlett, J. D., Salo, T. A., et al. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200203000-00006 · Cited by 109
Leivonen, S., Chantry, A., Häkkinen, L., Han, J., & Kähäri, V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206535200 · Cited by 102
Evans, K. D., Lau, S. T., Oberbauer, A. M., & Martin, R. B. (2003) · Bone · doi:10.1016/s8756-3282(02)00974-2 · Cited by 101
Unweighting Accelerates Tidemark Advancement in Articular Cartilage at the Knee Joint of Rats
O'Connor, K. M. D. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.4.580 · Cited by 94
Muehleman, C., Green, J. M., Williams, J. M., Kuettner, K. E., Thonar, E. J.-M. A., & Sumner, D. R. (2002) · Osteoarthritis and Cartilage · doi:10.1053/joca.2001.0506 · Cited by 81
Lehmann, H.-J., Mouritzen, U., Christgau, S., Cloos, P. A., & Christiansen, C. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.530 · Cited by 75
Preclinical pharmacology of alendronate
Rodan, G. A., Seedor, J. G., & Balena, R. (1993) · Osteoporosis International · doi:10.1007/bf01623001 · Cited by 67
Self-citationMyers, S. L., Brandt, K. D., Burr, D. B., O’Connor, B. L., & Albrecht, M. E. (1999) · PubMed · Cited by 67
Dragomir, A. D., Kraus, V. B., Renner, J. B., Luta, G., Clark, A. L., Vilı́m, V., Hochberg, M. C., Helmick, C. G., & Jordan, J. M. (2002) · Osteoarthritis and Cartilage · doi:10.1053/joca.2002.0816 · Cited by 61
Activation of Transforming Growth Factor β in Chondrocytes Undergoing Endochondral Ossification
D’Angelo, M., Sarment, D. P., Billings, P. C., & Pacifici, M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.12.2339 · Cited by 61
Partial chondroprotective effect of zoledronate in a rabbit model of inflammatory arthritis.
Podworny, N. V., Kandel, R. A., Renlund, R., & Grynpas, M. D. (1999) · PubMed · Cited by 49
Stearns, M. E., & Wang, M. (1998) · Clinical & Experimental Metastasis · doi:10.1023/a:1006524610591 · Cited by 43
Davoli, M. A., Lamplugh, L., Beauchemin, A., Chan, K., Mordier, S., Mort, J. S., Murphy, G., Docherty, A., Leblond, C. P., & Lee, E. R. (2001) · Developmental Dynamics · doi:10.1002/dvdy.1160 · Cited by 40
Peter, C. P., Guy, J., Shea, M., Bagdon, W., Kline, W. F., & Hayes, W. C. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12261-1 · Cited by 33
Osteoporotic fractures: ignorance is bliss?
Bauer, D. C. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00541-6 · Cited by 24
A Soluble Transforming Growth Factor-β (TGF-β) Type I Receptor Mimics TGF-β Responses
Docagne, F., Colloc’h, N., Bougueret, V., Page, M., Paput, J., Tripier, M., Dutartre, P., MacKenzie, E. T., Buisson, A., Komesli, S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010915200 · Cited by 13
Cited by
Kraus, V. B., Huebner, J. L., DeGroot, J., & Bendele, A. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.04.015 · Cited by 1,771
Hayami, T., Pickarski, M., Zhuo, Y., Wesolowski, G. A., Rodan, G. A., & Duong, L. T. (2006) · Bone · doi:10.1016/j.bone.2005.08.007 · Cited by 624
Self-citationOsteoarthritis — an untreatable disease?
Wieland, H. A., Michaelis, M., Kirschbaum, B. J., & Rudolphi, K. A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1693 · Cited by 585
Osteoarthritis development in novel experimental mouse models induced by knee joint instability
Kamekura, S., Hoshi, K., Shimoaka, T., Chung, U., Chikuda, H., Yamada, T., Uchida, M., Ogata, N., Seichi, A., Nakamura, K., et al. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.03.004 · Cited by 579
Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain
Zhu, S., Zhu, J., Zhen, G., Hu, Y., An, S., Li, Y., Zheng, Q., Chen, Z., Yang, Y., Wan, M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci121561 · Cited by 456
Metadata
- Authors
- Hayami, T., Pickarski, M., Wesolowski, G. A., Mclane, J., Bone, A., Destefano, J., Rodan, G. A., & Duong, L. T.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2004-04
- Volume
- 50
- Issue
- 4
- Pages
- 1193-1206
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2047606883
- Cited by
- 560
- References
- 48
- FWCI
- 12.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.